ICOS-Expressing Lymphocytes Promote Resolution of CD8-Mediated Lung Injury in a Mouse Model of Lung Rejection
Creators
- 1. Indiana University
- 2. University of Chicago
- 3. Harvard University
Description
Acute rejection, a common complication of lung transplantation, may promote obliterative bronchiolitis leading to graft failure in lung transplant recipients. During acute rejection episodes, CD8+ T cells can contribute to lung epithelial injury but the mechanisms promoting and controlling CD8-mediated injury in the lung are not well understood. To study the mechanisms regulating CD8+ T cell–mediated lung rejection, we used a transgenic model in which adoptively transferred ovalbumin (OVA)-specific cytotoxic T lymphocytes (CTL) induce lung injury in mice expressing an ovalbumin transgene in the small airway epithelium of the lungs (CC10-OVA mice). The lung pathology is similar to findings in humans with acute lung transplant. In the presence of an intact immune response the inflammation resolves by day 30. Using CC10-OVA.RAG-/- mice, we found that CD4+ T cells and ICOS+/+ T cells were required for protection against lethal lung injury, while neutrophil depletion was not protective. In addition, CD4+Foxp3 + ICOS+ T cells were enriched in the lungs of animals surviving lung injury and ICOS+/+ Tregs promoted survival in animals that received ICOS-/- T cells. Direct comparison of ICOS-/- Tregs to ICOS+/+ Tregs found defects in vitro but no differences in the ability of ICOS-/- Tregs to protect from lethal lung injury. These data suggest that ICOS affects Treg development but is not necessarily required for Treg effector function.
Files
journal.pone.0072955.pdf
Files
(2.7 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:f8c1a27e4c6b5fdbe145d3338856e720 |
2.7 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0072955
- Other
- oai:uchicago.tind.io:8853
Funding
- NIH/NIAID
- K08AI059105
- American Society of Transplantation/Wyeth
- NIH/NIAID
- R01AI67697
- Blowitz-Ridgeway Foundation
- American Cancer Society–Illinois Division
- Cancer Research Institute
- Irvington Institute Fellowship Program
- American Heart Association
- Scientist Development Grant
- Roche Organ Transplantation Research Foundation
- NIH
- R01CA069212